Multiple sclerosis-associated uveitis successfully controlled with ofatumumab
While the benefits of ofatumumab have been well reported in MS, this is the first case report to describe the successful treatment of MS-associated uveitis with ofatumumab. Ofatumumab may prove to be an effective therapeutic option for these patients, with the additional benefit of self-administration. Further studies would be beneficial to identify the patients who would most benefit from this treatment.
Authors
- Julia Xia (ORCID: https://orcid.org/0000-0002-0843-7245)
- Andrew B. Wolf (ORCID: https://orcid.org/0000-0002-1406-4107)
- Amit K. Reddy (ORCID: https://orcid.org/0000-0002-5097-823X)
- Ian J. McClain
- Mark Dacey
- Alan G. Palestine
- Soufiane Azargui
Institutions
- Rocky Mountain Orthopedics (US)
- Rocky Mountain MS Center (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of Ophthalmic Inflammation and Infection
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1186/s12348-025-00543-0
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00